Avian Flu

DATE: 07/22/2024
TO: Healthcare Providers, Healthcare Facilities, Clinical Laboratories, and Local Health
Departments
FROM: New York State Department of Health (NYSDOH) Wadsworth Center and Division of
Epidemiology, Bureau of Communicable Disease Control (BCDC)
The purpose of this advisory is to provide guidance regarding surveillance for influenza (including
highly pathogenic avian influenza A(H5N1)) in patients with severe respiratory illness and the
submission of specimens to Wadsworth Center.
Summary

  • In response to the ongoing and extensive global outbreak of highly pathogenic avian influenza
    (HPAI) A(H5N1) in wild birds, poultry, and dairy cattle, the Centers for Disease Control and
    Prevention (CDC) is encouraging year-round testing for influenza among persons with severe
    respiratory illness.
  • NYSDOH and the CDC request that respiratory samples from persons hospitalized with
    laboratory confirmed influenza, particularly patients receiving intensive care unit (ICU) level care,
    be promptly forwarded to the Wadsworth Center Virology Laboratory for additional testing,
    including subtyping, whole genome sequencing, and antiviral resistance testing.
  • Laboratories, hospitals, and clinical providers should recognize that adherence to
    recommendations for influenza testing and sample submission are important steps for human
    HPAI A(H5N1) surveillance in the United States (U.S.), especially during the summer when
    influenza testing may not be routine and exposure to poultry, cattle, and swine may increase
    during agricultural fair season.
  • If you suspect a patient has a novel influenza A virus infection based on an influenza A
    positive laboratory result in combination with clinical history and exposures, immediately
    contact the NYSDOH at 518-473-4439 or 1-866-881-2809 after hours and the local health
    department (LHD)1 where the patient resides.
    1 https://www.health.ny.gov/contact/contact_information/
    Health Advisory: Influenza Testing among Persons with Severe Respiratory Illness
    During Periods of Low Influenza Virus Circulation
    Please distribute immediately to: Clinical Laboratories, Hospitals, Local Health Departments,
    Physicians, Physician Assistants, Nurses, Nurse Practitioners, Facility Staff in The Departments of
    Emergency Medicine, Infectious Disease, Infection Prevention and Control, Epidemiology,
    Laboratory Medicine, Medical Directors, Directors of Nursing, and all patient care areas
    Page 2 of 3
    Background
    Public health agencies in the U.S. and clinical partners continue to monitor and respond to the global
    outbreak of HPAI A(H5N1). As of July 18, more than 100 million poultry have been affected in 48
    states in the current U.S. outbreak, the largest domestic outbreak of avian influenza in poultry in
    recorded history. Additionally, HPAI A(H5N1) has been detected in more than 163 U.S. dairy cattle
    herds in 13 states and sporadically in other animals2
    .
    The currently circulating strain of HPAI A(H5N1) poses a low risk to the health of the general public.
    However, to date, nine human cases of A(H5N1) infection associated with the outbreak in U.S. dairy
    cows3 and poultry4 have been reported. While the number of human cases nationally remains small,
    influenza viruses are known to be unpredictable and highly mutable with the potential for a rapid
    change in tropism and transmission, which is a concern given the extent of spread in birds and novel
    detections in dairy cows and other animals.
    Please visit https://www.cdc.gov/bird-flu/situation-summary/index.html for the most up-to-date
    information.
    Recommended actions:
  1. Submit to Wadsworth Center year-round all positive influenza samples from hospitalized
    patients requiring ICU care.
  2. Conduct enhanced influenza surveillance during months when seasonal influenza
    incidence is typically low (May through September).
  • Continue ordering influenza testing and subtyping on patients with respiratory illness.
  • NYSDOH recommends increased levels of clinical suspicion of influenza in patients with
    respiratory illness who are at higher risk for contracting avian or novel influenza, such as those
    with a history of exposure to dairy cattle, wild birds, poultry, or swine (pigs).
  • If you have a patient with conjunctival symptoms (with or without respiratory symptoms) and who
    is at high risk for contracting avian or novel influenza, such as recent exposure to dairy cattle,
    contact the local health department (LHD)5 where the patient resides for testing guidance. If
    unable to reach the LHD where the patient resides, contact the NYSDOH Bureau of
    Communicable Disease Control at 518-473-4439 during business hours or at 866-881-2809
    after hours.
  1. Submit to Wadsworth Center all influenza positive samples detected in hospitalized
    persons NOT requiring ICU care until December 31, 2024, for subtyping, sequencing,
    and other specialized analyses, as well as potentially forwarding to CDC for their repository.
  • In the event of an outbreak, please contact the NYSDOH at 518-473-4439 for guidance.
    Specimen and shipping instructions
  • Specimens acceptable for influenza testing at Wadsworth Center include nasopharyngeal swabs
    (NPs), oropharyngeal swabs (OPs), and nasal swabs (NSs) in viral transport media (VTM) or
    universal transport media (UTM).
  • Flocked swabs are preferred. Sterile Dacron® or rayon swabs with plastic or metal handles may
    also be used. Do NOT use cotton or calcium alginate swabs or swabs with wooden sticks. Place
    the swab in liquid VTM or UTM. The swabs and media used for routine SARS-CoV-2 or influenza
    (polymerase chain reaction (PCR)) testing can be used. Do NOT use saline or dry swabs.
  • Specimens MUST be kept cool until they reach Wadsworth Laboratory. Refrigerate OR store
    specimens in cooler with frozen gel packs until ready to ship. Specimens should be shipped
    2 https://www.cdc.gov/bird-flu/situation-summary/index.html
    3 https://www.cdc.gov/media/releases/2024/p-0703-4th-human-case-h5.html
    4 https://www.cdc.gov/media/releases/2024/p-0715-confirm-h5.html
    5 https://www.health.ny.gov/contact/contact_information/
    Page 3 of 3
    overnight on frozen gel packs.
  • Specifics regarding influenza specimen collection and shipping to Wadsworth Center can be
    found at: https://www.wadsworth.org/programs/id/virology/services/specimen-collection
  • A shipping manifest from an electronically submitted Remote Order OR an Infectious Disease
    Requisition (IDR)6
    form requesting influenza testing with subtyping should accompany all
    specimens sent to Wadsworth.
  • For questions about shipping on holidays or weekends, please call 518-474-4177.
  • Please ship specimens to:
    David Axelrod Institute
    Virology Laboratory
    Wadsworth Center
    New York State Dept. of Health
    120 New Scotland Ave.
    Albany, NY 12208
    Infection Prevention Considerations
    Standard, Contact, and Airborne precautions, including the use of eye protection, are
    recommended for the collection of respiratory and other specimens and medical evaluation.
  • Patients with suspected HPAI A(H5N1) infection who present to a healthcare facility should be
    placed in an airborne infection isolation room (AIIR).
  • If a patient presents to a healthcare facility at which an AIIR is not available, the patient should
    be instructed to wear a facemask and should be placed in an examination room with the door
    closed until discharge or transfer to a facility with an AIIR.
  • Additional infection prevention and control guidance for healthcare facilities with or without an
    AIIR, including additional patient placement information and cleaning and disinfection steps, is
    available7
    .
    NYSDOH appreciates your continued support in this effort to prevent and control influenza, and
    the partnership with laboratories, hospitals, and providers to immediately identify and contain
    potential human cases of novel influenza in the U.S.
    Resources and Questions
  • Questions regarding submission of specimens to Wadsworth Center can be directed to
    wcid@health.ny.gov.
  • Questions pertaining to enrollment to Wadsworth Center CLIMS for access to remote ordering and
    access to electronic test reports can be directed to climsoutreach@health.ny.gov.
  • General questions about suspected A(H5N1) cases can be directed to the NYSDOH BCDC at 1-
    866-881-2809 evenings, weekends, and holidays or by email at BCDC@health.ny.gov.
  • NYC based clinicians should contact the healthcare provider access line at 1-866-692-3641
  • General questions about influenza infection control in hospitals, nursing homes, and diagnostic and
    treatment centers can be sent to icp@health.ny.gov
  • Additional NYSDOH guidance for clinicians regarding Highly Pathogenic Avian Influenza A(H5N1)
    is available at: https://commerce.health.state.ny.us/hpn/ctrldocs/alrtview/postings/NY_Advisory_-
    _HPAI_Identification_of_Human_Infection_2024_1712853441619_0.0.pdf
  • General NYSDOH avian influenza information is available at:
    https://www.health.ny.gov/diseases/communicable/influenza/avian/
    6 https://www.wadsworth.org/programs/id/idr
    7 https://www.cdc.gov/bird-flu/hcp/novel-flu-infection-control/?CDC_AAref_Val=https://www.cdc.gov/flu/avianflu/novel-flu-infection-control.htm

Leave a comment

Your email address will not be published. Required fields are marked *